Agree - article is very accurate I hv invested in ARTH for 3 years - not coming out so easily - but mgmt acting like most OTC biotechs who screw up by over promise - under delivery - more dilutions - delays - excuses for delay - blaming everyone else for delays
The change of tone of Dr N related to ce application is very concerning - after 9 months of successful trial no ce mark application is filed and Dr N is not giving any valid explanation and being very opaque
Getting more concerned that we are going to get royally screwed